ARDS (Aridis Pharmaceuticals) Other Current Liabilities: $0.02 Mil (As of Sep. 2023)


ARDS Aridis Pharmaceuticals Inc ARDS
12 GF Score
Price $0.00
View Full Analysis

What is Aridis Pharmaceuticals Other Current Liabilities?

Aridis Pharmaceuticals ARDS -99.00% 12 Other Current Liabilities is $0.02 Mil as of Sep. 2023. GuruFocus rates ARDS with a GF Score™ of 12/100.

Aridis Pharmaceuticals's other current liabilities for the quarter that ended in Sep. 2023 was $0.02 Mil.

Aridis Pharmaceuticals's quarterly other current liabilities increased from Mar. 2023 ($0.02 Mil) to Jun. 2023 ($0.02 Mil) but then declined from Jun. 2023 ($0.02 Mil) to Sep. 2023 ($0.02 Mil).

Aridis Pharmaceuticals's annual other current liabilities increased from Dec. 2020 ($0.04 Mil) to Dec. 2021 ($0.11 Mil) but then declined from Dec. 2021 ($0.11 Mil) to Dec. 2022 ($0.02 Mil).

Aridis Pharmaceuticals Other Current Liabilities Related Terms

Aridis Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Aridis Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aridis Pharmaceuticals Other Current Liabilities Chart

Aridis Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial 0.45 0.00 0.04 0.11 0.02

Aridis Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02
ARDS
12GF Score
Aridis Pharmaceuticals Inc ARDS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aridis Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.02 Mil mean?
Aridis Pharmaceuticals (ARDS) has a Other Current Liabilities of $0.02 Mil as of Sep. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Aridis Pharmaceuticals.
Is Aridis Pharmaceuticals' Other Current Liabilities too high?
Aridis Pharmaceuticals' current Other Current Liabilities is $0.02 Mil. Overall, Aridis Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aridis Pharmaceuticals' Other Current Liabilities compare to ARTL and REVB?
Aridis Pharmaceuticals' Other Current Liabilities of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Aridis Pharmaceuticals. Aridis Pharmaceuticals's current Other Current Liabilities is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aridis Pharmaceuticals stock overvalued right now?
Aridis Pharmaceuticals (ARDS) has a current Other Current Liabilities of $0.02 Mil. The current Other Current Liabilities is $0.02 Mil. Aridis Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Aridis Pharmaceuticals (ARDS), the current Other Current Liabilities is $0.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aridis Pharmaceuticals Business Description

Address 983 University Avenue, Building B, Los Gatos, CA, USA, 95032
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
12GF Score

Get the complete analysis for ARDS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price